| |
The healthcare system’s drive to create more efficient and cost-effective healing techniques, while saving labor and treatment costs, is aiding the U.S. moist wound dressings markets. Despite its slow technological progress, introductions of unique products that provide leading-edge initiatives are bolstering the market’s prospects.
New analysis from Frost & Sullivan, U.S. Moist Wound Dressings Markets, reveals that the market earned revenues of $312.5 million in 2005 and estimates this to reach $402.6 million in 2012.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Moist Wound Dressings Markets, then send an e-mail to Melina Trevino - Corporate Communications at melina.trevino[.]frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.
Product development is critical in the moist wound dressing market since increasing demand for more effective wound dressings compels manufacturers to distinguish themselves through unique product features. Participants also need to be wary of the rising market acceptance of substitute products such as antimicrobial, active dressings and other advanced techniques. To thwart off competition, manufacturers are create new categories of moist wound dressings, combining composites such as collagen, hyaluronic acid, and silver with moist wound dressings or combining several moist wound-dressing composites.
Moist wound dressings’ clinical benefits of faster healing rates, reduced scarring, and higher absorbency improve results. Moreover, healthcare care facilities and providers are shifting to moist wound dressings over dry gauze since its total cost of treatment is lower by almost 60 percent.
“Unlike dry and impregnated gauze, moist wound dressings are not changed as frequently, thus reducing high labor costs associated with clinicians who administer the treatment,” says Frost & Sullivan Research Analyst Sheila Ewing. “These dressings also facilitate cell repair, while reducing pain during dressing changes.”
Manufacturers should offer evidence of not only the efficiency of their products, but also highlight cost effectiveness in response to apprehensions regarding growing healthcare expenditure. Since clinical evidence is the basis of reimbursement decisions, there is a need for more sophisticated methods of demonstrating the cost benefit of a product.
“Market participants must provide rigorous long-term clinical and economic evidence by building strong relationships with key opinion leaders and conducting research in partnership with key institutions,” notes Ewing. ”Cost-benefit analysis is not only important for gaining clinicians’ approval for a treatment, but also for maintaining or garnering market share.”
The U.S. Moist Wound Dressings Markets is part of the Medical Devices Growth Partnership Services, which includes research services in the following markets: U.S. Carotid and Intracranial Vascular Devices Markets, U.S. Endoscopes Markets, U.S. Congestive Heart Failure Device Markets, U.S. Cardiac Rhythm Management Markets. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews are available to the press.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.
|
melina.trevino[.]frost.com 
